X
Software Functionality Revealed in Detail
We’ve opened the hood on every major category of enterprise software. Learn about thousands of features and functions, and how enterprise software really works.
Get free sample report

Compare Software Solutions
Visit the TEC store to compare leading software solutions by funtionality, so that you can make accurate and informed software purchasing decisions.
Compare Now
 

 biotech pharma


Biopharma Contracts and Chargeback Systems: A Peek into the Market
Managing revenues, risk, and compliance is critical to the survival of biotech and pharmaceutical companies (biopharma). But the complexity of revenue

biotech pharma  to the survival of biotech and pharmaceutical companies (biopharma). But the complexity of revenue management in biopharma, such as contract and chargebacks, is not handled by ERP solutions. This article looks at contracts and chargeback systems functionality for biopharma and how that could help companies in other industries effectively manage their revenue streams.

Read More


Software Functionality Revealed in Detail

We’ve opened the hood on every major category of enterprise software. Learn about thousands of features and functions, and how enterprise software really works.

Get free sample report
Compare Software Solutions

Visit the TEC store to compare leading software by functionality, so that you can make accurate and informed software purchasing decisions.

Compare Now

Documents related to » biotech pharma

SaaS Buyer's Guide for Wholesale and Distribution


SaaS, despite its phenomenal popularity, is certainly not one-size-fits-all. You need to consider decision criteria such as fit, return on investment, and risk. Learn how SaaS works, who the major vendors are, how SaaS can help your business grow, and how to find the SaaS solution that’s right for you. It’s all in this comprehensive SaaS Buyer’s Guide for Wholesale and Distribution from TEC and SupplyChainBrain.

From a business requirements perspective, the defining characteristic of wholesale and distribution (W&D) organizations is that they operate as intermediate agents between manufacturers and retailers. Their top business needs thus focus on requirements for:

  • processing high volumes of transactions,
  • maintaining constant communication between upstream and downstream collaborators (manufacturers and retailers/customers, respectively), and
  • managing products for multiple competitors within the same warehouse or distribution center

In this guide we will explore considerations for W&D organizations that are considering adoption of the SaaS delivery model, and examine the particular business issues that arise from this change.Specifically, we will address the following considerations:

  • the differences between SaaS and on-premise delivery models
  • SaaS architectures
  • SaaS pros, cons, and other considerations
  • selection criteria for SaaS-based applications
  • viable wholesale and distribution SaaS vendors

Later in this guide, we’ll provide examples of SaaS delivery model success stories, as well as a SaaS IT directory, segmented according to business area.


Table of Contents


Preface

Software as a Service: A Buyer’s Guide


Spotlight on Adaptability and Agility

Thought Leadership from SAP
SAP’s Perspective on Software as a Service

SAP Case Study
Johnson Products Capitalizing on New Sales after 30-day SAP Deployment


Spotlight on Manufacturing and Distribution

Thought Leadership from Epicor
SaaS ERP for Small Manufacturers and Distributors

TECSYS Case Study
LifeScience Logistics Achieves 99.97% Inventory Accuracy with TECYS’ EliteSeries for Healthcare


Spotlight on Growing Your Company with SaaS

Thought Leadership from NetSuite
The Benefits of a Business Management Software Suite for High-growth and Midsized Businesses: Overcoming the Barriers of Stand-alone Business Applications

NetSuite Case Study
Woodworking Machinery Maker Cuts Costs, Grows Efficiency with NetSuite

NetSuite Case Study
NetSuite Helps Manufacturer Take Advantage of Fast Market Growth


Spotlight on Distribution Centers

Thought Leadership from Bond International Software
Cloud Computing for Your Distribution Workforce

IBS Case Study
Konaflex Focuses on its Core Business with IBS Distribution Management Software


Vendor Directory


Download the full copy of the TEC 2010 SaaS Buyer’s Guide for wholesale and distribution.



Report Preview


What Are the Differences between the SaaS and On-premise Delivery Models?



Defining the on-premise delivery model is relatively straightforward:

  • The software is acquired by the customer up-front.
  • The software is installed, deployed, managed, and maintained at the customer’s site, generally with a great degree of involvement by the customer.
  • The customer provides the in-house infrastructure (e.g., servers, hardware, networks) to support the software.


Defining the SaaS model is slightly more complex, since different SaaS vendors offer different definitions. We’ll explore these variations in more detail shortly, but for now we’ll note the following SaaS characteristics:

  • The software vendor provides customers with access to the software via the Internet.
  • The customer pays for this service on a subscription basis (normally per user, per month, or per number of transactions).
  • The vendor is responsible for maintenance, upgrades, and software support, as well as the supporting infrastructure.

The major difference between the on-premise and SaaS delivery model lies in the ownership of the software. In the on-premise model, once the software is purchased, the customer owns it. In the SaaS delivery model, the software is not owned by the customer: it is provided to the customer in the same manner as any other service.


Download the full copy of the TEC 2010 SaaS Buyer’s Guide for wholesale and distribution.

biotech pharma   Read More

A Portrait of the Enterprise Software User in the Pharmaceutical Industry


The pharmaceutical industry faces strict regulatory requirements in the approval of drugs for treatment of diseases. Software can help pharma successfully manage compliance and risk and quickly bring effective and safe drugs to market. Read this article by TEC product manager Rahim Kaba on the types of software and functional priorities that pharma users seek to streamline their operations and manage regulatory compliance.

biotech pharma   Read More

The State of Global Clinical Research Trials


New technologies and changing economic conditions have triggered a number of changes in the pharmaceuticals, life sciences, and biotech sectors. Increased global sales of life sciences products and growing demand for drugs present drug industry companies with a host of opportunities. However, the mandate for clinical trials has led to considerable inflation in their research and development (R&D) expenditure. The resolution lies in using emerging markets as an alternative to conduct these trials. Thanks to new technologies, the cloud, and social media/online portals, the pharmaceuticals, life sciences and biotech sectors can make the most of the emerging opportunities. Learn how.

biotech pharma   Read More

The Executive Guide to Contract and Chargeback Management


Life sciences companies are struggling to manage large group purchase organization (GPO) contracts, process chargeback submissions, and ensure that pricing policies comply with regulatory requirements. Costs and risks are escalating as these demands outstrip the capabilities of existing systems. Learn how contract and chargeback management solutions can help you maximize growth while limiting regulatory risk.

biotech pharma   Read More

Specialty Biopharmaceuticals Manufacturer Selects Zycus


An unnamed pharmaceuticals manufacturing company in the U.K. recently selected Zycus’ Spend Analysis solution. Zycus uses an artificial intelligence (AI)-based spend classification engine and leverages its deep expertise in analyzing and mining pharmaceuticals' corporate spending data for performance improvement.

biotech pharma   Read More

Taking Stock of TAKE Supply Chain Solutions - Part 1


Over the past several years I’ve repeatedly heard of a supply chain management (SCM) software and professional services company called ClearOrbit that was recently renamed TAKE Supply Chain. I admit to initially being in a quandary how to figure out the company’s exact value proposition and differentiation, given that its corporate Web site and press release (PR) messages

biotech pharma   Read More

RedShift 2012: RedPrairie’s Three-year Transformational Journey


The recently held RedShift 2012 user conference was reportedly a huge success for RedPrairie, a vendor of supply chain management (SCM), workforce management (WFM), and multi-channel retail solutions. (I could not attend the multi-day event in person, but I was kindly debriefed by RedPrairie after the event). The business world has lately been transformed by a host of phenomena such as digital

biotech pharma   Read More

How Inventory Optimization Can Increase Your Profitability


One of the largest expenses for distributors and wholesalers is stock. Many have difficulty finding the perfect balance between ensuring products are available when they’re needed and not holding too much inventory. So, how is it possible to increase profitability while lowering inventory costs? By exploiting an inventory optimization system, businesses increase automation and collaboration—allowing greater profitability.

biotech pharma   Read More

Demand Management, Inc.-Supply Chain Planning for the SMB


Demand Management Inc. has been very busy as of late, with a recent flurry of new products and features. In a series of press releases, Demand Management has recently announced the availability of the Demand Solutions platform as a software-as-a-service (SaaS) offering; configurable workflows that provide alerts for exceptions and escalations; a new predictive lead time capability; and new

biotech pharma   Read More

IBS-Slow but Steady (and Demand-Driven) May Win the SCM Race


IBS, a conservative Swedish enterprise resource planning and supply chain management, seems to be making right moves to remain the leader within its selected segments. However, the road to becoming uniformly globally recognized player will not be smooth.

biotech pharma   Read More